{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:28:11Z","timestamp":1792790891611,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beyond Celiac, Coeliac UK","id":[{"id":"https:\/\/ror.org\/042404z19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Oxford-BMS Translational Fellowship Scheme"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WSSS 211276\/Z\/18\/Z & 218597\/Z\/19\/Z"],"award-info":[{"award-number":["WSSS 211276\/Z\/18\/Z & 218597\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WSSS 211276\/Z\/18\/Z & 218597\/Z\/19\/Z)"],"award-info":[{"award-number":["WSSS 211276\/Z\/18\/Z & 218597\/Z\/19\/Z)"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WSSS 211276\/Z\/18\/Z & 218597\/Z\/19\/Z"],"award-info":[{"award-number":["WSSS 211276\/Z\/18\/Z & 218597\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WSSS 211276\/Z\/18\/Z & 218597\/Z\/19\/Z, 222426\/Z\/21\/Z)"],"award-info":[{"award-number":["WSSS 211276\/Z\/18\/Z & 218597\/Z\/19\/Z, 222426\/Z\/21\/Z)"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Johnson and Johnson Innovative Medicine via the Cartography Consortium"},{"name":"JDRF\/Wellcome Diabetes and Inflammation Laboratory Strategic Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The immune\u2013epithelial\u2013stromal interactions underpinning intestinal damage in celiac disease (CD) are incompletely understood. To address this, we performed single-cell transcriptomics (RNA sequencing; 86,442 immune, parenchymal and epithelial cells; 35 participants) and spatial transcriptomics (20 participants) on CD intestinal biopsy samples. Here we show that in CD, epithelial populations shifted toward a progenitor state, with interferon-driven transcriptional responses, and perturbation of secretory and enteroendocrine populations. Mucosal T cells showed numeric and functional changes in regulatory and follicular helper-like CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells, intraepithelial lymphocytes, CD8\n                    <jats:sup>+<\/jats:sup>\n                    and \u03b3\u03b4 T cell subsets, with skewed T cell antigen receptor repertoires. Mucosal changes remained detectable despite treatment, representing a persistent immune\u2013epithelial \u2018scar\u2019. Spatial transcriptomics defined transcriptional niches beyond those captured in conventional histological scores, including CD-specific lymphoid aggregates containing T cell\u2013B cell interactions. Receptor\u2013ligand spatial analyses integrated with disease susceptibility gene expression defined networks of altered chemokine and morphogen signaling, and provide potential therapeutic targets for CD prevention and treatment.\n                  <\/jats:p>","DOI":"10.1038\/s41590-025-02146-2","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T05:02:00Z","timestamp":1746507720000},"page":"947-962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Immune\u2013epithelial\u2013stromal networks define the cellular ecosystem of the small intestine in celiac disease"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2365-2012","authenticated-orcid":false,"given":"Michael E. B.","family":"FitzPatrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agne","family":"Antanaviciute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Dunstan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-0194","authenticated-orcid":false,"given":"Karolina","family":"K\u00fcnnapuu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Trzupek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9694-2216","authenticated-orcid":false,"given":"Nicholas M.","family":"Provine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie L.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6461-252X","authenticated-orcid":false,"given":"Lucy C.","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane I.","family":"Pernes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5733-3285","authenticated-orcid":false,"given":"Ricardo C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5329-9072","authenticated-orcid":false,"given":"Sarah C.","family":"Sasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7580-2567","authenticated-orcid":false,"given":"Dominik","family":"Aschenbrenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devika","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astor","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Ruane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4032-7249","authenticated-orcid":false,"given":"Elizabeth","family":"Soilleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-6366","authenticated-orcid":false,"given":"Sarah A.","family":"Teichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1179-4021","authenticated-orcid":false,"given":"Calliope A.","family":"Dendrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6111-7355","authenticated-orcid":false,"given":"Holm H.","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4307-9161","authenticated-orcid":false,"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"2146_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-018-0054-z","volume":"5","author":"K Lindfors","year":"2019","unstructured":"Lindfors, K. et al. Coeliac disease. Nat. Rev. Dis. Primers 5, 3 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2146_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41575-020-00378-1","volume":"18","author":"L Kivel\u00e4","year":"2021","unstructured":"Kivel\u00e4, L. et al. Current and emerging therapies for coeliac disease. Nat. Rev. Gastroenterol. Hepatol. 18, 181\u2013195 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2146_CR3","doi-asserted-by":"publisher","unstructured":"Sollid, L. M. The roles of MHC class II genes and post-translational modification in celiac disease. Immunogenetics https:\/\/doi.org\/10.1007\/s00251-017-0985-7 (2017).","DOI":"10.1007\/s00251-017-0985-7"},{"key":"2146_CR4","doi-asserted-by":"publisher","first-page":"562434","DOI":"10.3389\/fgene.2020.562434","volume":"11","author":"Avander Graaf","year":"2021","unstructured":"Graaf, Avander et al. Systematic prioritization of candidate genes in disease loci identifies TRAFD1 as a master regulator of IFN\u03b3 signaling in celiac disease. Front. Genet. 11, 562434 (2021).","journal-title":"Front. Genet."},{"key":"2146_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.aah5298","volume":"356","author":"R Bouziat","year":"2017","unstructured":"Bouziat, R. et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science 356, 44\u201350 (2017).","journal-title":"Science"},{"key":"2146_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.chom.2018.10.004","volume":"24","author":"R Bouziat","year":"2018","unstructured":"Bouziat, R. et al. Murine norovirus infection induces TH1 inflammatory responses to dietary antigens. Cell Host Microbe 24, 677\u2013688 (2018).","journal-title":"Cell Host Microbe"},{"key":"2146_CR7","doi-asserted-by":"publisher","first-page":"l231","DOI":"10.1136\/bmj.l231","volume":"34","author":"CR Kahrs","year":"2019","unstructured":"Kahrs, C. R. et al. Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort. BMJ 34, l231\u2013l238 (2019).","journal-title":"BMJ"},{"key":"2146_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.gastro.2024.03.042","volume":"167","author":"V Abadie","year":"2024","unstructured":"Abadie, V., Han, A. S., Jabri, B. & Sollid, L. M. New insights on genes, gluten, and immunopathogenesis of celiac disease. Gastroenterology 167, 4\u201322 (2024).","journal-title":"Gastroenterology"},{"key":"2146_CR9","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.4049\/jimmunol.1601693","volume":"198","author":"B Jabri","year":"2017","unstructured":"Jabri, B. & Sollid, L. M. T cells in celiac disease. J. Immunol. 198, 3005\u20133014 (2017).","journal-title":"J. Immunol."},{"key":"2146_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathmechdis-031521-032634","volume":"18","author":"R Iversen","year":"2022","unstructured":"Iversen, R. & Sollid, L. M. The immunobiology and pathogenesis of celiac disease. Annu. Rev. Pathol. 18, 47\u201370 (2022).","journal-title":"Annu. Rev. Pathol."},{"key":"2146_CR11","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1126\/science.1074129","volume":"297","author":"L Shan","year":"2002","unstructured":"Shan, L. et al. Structural basis for gluten intolerance in celiac sprue. Science 297, 2275\u20132276 (2002).","journal-title":"Science"},{"key":"2146_CR12","doi-asserted-by":"publisher","unstructured":"Christophersen, A. et al. Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-019-0403-9 (2019).","DOI":"10.1038\/s41591-019-0403-9"},{"key":"2146_CR13","doi-asserted-by":"publisher","first-page":"15134","DOI":"10.1073\/pnas.1901561116","volume":"116","author":"R Iversen","year":"2019","unstructured":"Iversen, R. et al. Efficient T cell\u2013B cell collaboration guides autoantibody epitope bias and onset of celiac disease. Proc. Natl Acad. Sci. USA 116, 15134\u201315139 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2146_CR14","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1053\/j.gastro.2018.12.013","volume":"156","author":"LS H\u00f8ydahl","year":"2019","unstructured":"H\u00f8ydahl, L. S. et al. Plasma cells are the most abundant gluten peptide MHC-expressing cells in inflamed intestinal tissues from patients with celiac disease. Gastroenterology 156, 1428\u20131439 (2019).","journal-title":"Gastroenterology"},{"key":"2146_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-020-2003-8","volume":"578","author":"V Abadie","year":"2020","unstructured":"Abadie, V. et al. IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease. Nature 578, 600\u2013604 (2020).","journal-title":"Nature"},{"key":"2146_CR16","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1136\/gutjnl-2021-326257","volume":"71","author":"A Levescot","year":"2022","unstructured":"Levescot, A., Malamut, G. & Cerf-Bensussan, N. Immunopathogenesis and environmental triggers in coeliac disease. Gut 71, 2337\u20132349 (2022).","journal-title":"Gut"},{"key":"2146_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1084\/jem.20060028","volume":"203","author":"B Meresse","year":"2006","unstructured":"Meresse, B. et al. Reprogramming of CTLs into natural killer\u2013like cells in celiac disease. J. Exp. Med. 203, 1343\u20131355 (2006).","journal-title":"J. Exp. Med."},{"key":"2146_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","volume":"21","author":"B Meresse","year":"2004","unstructured":"Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357\u2013366 (2004).","journal-title":"Immunity"},{"key":"2146_CR19","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S2468-1253(19)30265-1","volume":"4","author":"C Cellier","year":"2019","unstructured":"Cellier, C. et al. Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study. Lancet Gastroenterol. Hepatol. 4, 960\u2013970 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2146_CR20","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","volume":"4","author":"M-L L\u00e4hdeaho","year":"2019","unstructured":"L\u00e4hdeaho, M.-L. et al. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study. Lancet Gastroenterol. Hepatol. 4, 948\u2013959 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2146_CR21","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/apt.15470","volume":"50","author":"H Mitchell","year":"2019","unstructured":"Mitchell, H. & Garg, M. Editorial: a non-dietary treatment for coeliac disease-two steps forward, one step back? Alimentary Pharmacol. Ther. 50, 955\u2013956 (2019).","journal-title":"Alimentary Pharmacol. Ther."},{"key":"2146_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","volume":"152","author":"JA Murray","year":"2017","unstructured":"Murray, J. A. et al. No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease. Gastroenterology 152, 787\u2013798 (2017).","journal-title":"Gastroenterology"},{"key":"2146_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2032441","volume":"385","author":"D Schuppan","year":"2021","unstructured":"Schuppan, D. et al. A randomized trial of a transglutaminase 2 inhibitor for celiac disease. N. Engl. J. Med. 385, 35\u201345 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2146_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S2468-1253(23)00107-3","volume":"8","author":"JA Murray","year":"2023","unstructured":"Murray, J. A. et al. Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial. Lancet Gastroenterol. Hepatol. 8, 735\u2013747 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2146_CR25","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/s41590-024-01867-0","volume":"25","author":"V Dotsenko","year":"2024","unstructured":"Dotsenko, V. et al. Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease. Nat. Immunol. 25, 1218\u20131230 (2024).","journal-title":"Nat. Immunol."},{"key":"2146_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41586-021-03852-1","volume":"597","author":"R Elmentaite","year":"2021","unstructured":"Elmentaite, R. et al. Cells of the human intestinal tract mapped across space and time. Nature 597, 250\u2013255 (2021).","journal-title":"Nature"},{"key":"2146_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/s41586-024-07793-3","volume":"632","author":"Y Harnik","year":"2024","unstructured":"Harnik, Y. et al. A spatial expression atlas of the adult human proximal small intestine. Nature 632, 1101\u20131109 (2024).","journal-title":"Nature"},{"key":"2146_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41385-021-00452-0","volume":"15","author":"I Lindeman","year":"2022","unstructured":"Lindeman, I. & Sollid, L. M. Single-cell approaches to dissect adaptive immune responses involved in autoimmunity: the case of celiac disease. Mucosal Immunol. 15, 51\u201363 (2022).","journal-title":"Mucosal Immunol."},{"key":"2146_CR29","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.immuni.2016.04.014","volume":"44","author":"V van Unen","year":"2016","unstructured":"van Unen, V. et al. Mass cytometry of the human mucosal immune system identifies tissue- and disease-associated immune subsets. Immunity 44, 1227\u20131239 (2016).","journal-title":"Immunity"},{"key":"2146_CR30","doi-asserted-by":"publisher","first-page":"13073","DOI":"10.1073\/pnas.1311861110","volume":"110","author":"A Han","year":"2013","unstructured":"Han, A. et al. Dietary gluten triggers concomitant activation of CD4+ and CD8+ \u03b1\u03b2 T cells and \u03b3\u03b4 T cells in celiac disease. Proc. Natl Acad. Sci. USA 110, 13073\u201313078 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2146_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32691-5","volume":"13","author":"N Atlasy","year":"2022","unstructured":"Atlasy, N. et al. Single cell transcriptomic analysis of the immune cell compartment in the human small intestine and in celiac disease. Nat. Commun. 13, 4920 (2022).","journal-title":"Nat. Commun."},{"key":"2146_CR32","doi-asserted-by":"publisher","first-page":"eadf4312","DOI":"10.1126\/sciimmunol.adf4312","volume":"8","author":"A Kornberg","year":"2023","unstructured":"Kornberg, A. et al. Gluten induces rapid reprogramming of natural memory \u03b1\u03b2 and \u03b3\u03b4 intraepithelial T cells to induce cytotoxicity in celiac disease. Sci. Immunol. 8, eadf4312 (2023).","journal-title":"Sci. Immunol."},{"key":"2146_CR33","doi-asserted-by":"publisher","first-page":"843086","DOI":"10.3389\/fimmu.2022.843086","volume":"13","author":"AD Ram\u00edrez-S\u00e1nchez","year":"2022","unstructured":"Ram\u00edrez-S\u00e1nchez, A. D. et al. Single-cell RNA sequencing of peripheral blood mononuclear cells from pediatric coeliac disease patients suggests potential pre-seroconversion markers. Front. Immunol. 13, 843086 (2022).","journal-title":"Front. Immunol."},{"key":"2146_CR34","doi-asserted-by":"crossref","unstructured":"Lindeman, I. et al. Longevity, clonal relationship and transcriptional program of celiac disease-specific plasma cells. J. Exp. Med. 218, e20200852 (2021).","DOI":"10.1084\/jem.20200852"},{"key":"2146_CR35","doi-asserted-by":"publisher","unstructured":"Parikh, K. et al. Colonic epithelial cell diversity in health and inflammatory bowel disease. Nature https:\/\/doi.org\/10.1038\/s41586-019-0992-y (2019).","DOI":"10.1038\/s41586-019-0992-y"},{"key":"2146_CR36","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-024-07571-1","volume":"635","author":"AJ Oliver","year":"2024","unstructured":"Oliver, A. J. et al. Single-cell integration reveals metaplasia in inflammatory gut diseases. Nature 635, 699\u2013707 (2024).","journal-title":"Nature"},{"key":"2146_CR37","doi-asserted-by":"publisher","first-page":"100128","DOI":"10.1016\/j.jtauto.2021.100128","volume":"4","author":"L Airaksinen","year":"2021","unstructured":"Airaksinen, L. et al. Dissecting the contribution of single nucleotide polymorphisms in CCR9 and CCL25 genomic regions to the celiac disease phenotype. J. Transl. Autoimmun. 4, 100128 (2021).","journal-title":"J. Transl. Autoimmun."},{"key":"2146_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93739","volume":"2","author":"ML Pekalski","year":"2017","unstructured":"Pekalski, M. L. et al. Neonatal and adult recent thymic emigrants produce IL-8 and express complement receptors CR1 and CR2. JCI Insight 2, e93739 (2017).","journal-title":"JCI Insight"},{"key":"2146_CR39","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nsmb.2817","volume":"21","author":"J Petersen","year":"2014","unstructured":"Petersen, J. et al. T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease. Nat. Struct. Mol. Biol. 21, 480\u2013488 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2146_CR40","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/mi.2010.36","volume":"3","author":"M Bodd","year":"2010","unstructured":"Bodd, M. et al. HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol. 3, 594\u2013601 (2010).","journal-title":"Mucosal Immunol."},{"key":"2146_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw7756","volume":"5","author":"G Goel","year":"2019","unstructured":"Goel, G. et al. Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci. Adv. 5, eaaw7756-15 (2019).","journal-title":"Sci. Adv."},{"key":"2146_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/00365521.1977.12031127","volume":"12","author":"K Baklien","year":"1977","unstructured":"Baklien, K., Brandtzaeg, P. & Fausa, O. Immunoglobulins in jejunal mucosa and serum from patients with adult coeliac disease. Scand. J. Gastroenterol. 12, 149\u2013159 (1977).","journal-title":"Scand. J. Gastroenterol."},{"key":"2146_CR43","doi-asserted-by":"publisher","first-page":"e20200852","DOI":"10.1084\/jem.20200852","volume":"218","author":"I Lindeman","year":"2020","unstructured":"Lindeman, I. et al. Longevity, clonal relationship, and transcriptional program of celiac disease\u2013specific plasma cells. J. Exp. Med. 218, e20200852 (2020).","journal-title":"J. Exp. Med."},{"key":"2146_CR44","doi-asserted-by":"publisher","first-page":"e20221346","DOI":"10.1084\/jem.20221346","volume":"220","author":"KM Nickerson","year":"2023","unstructured":"Nickerson, K. M. et al. Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in mice. J. Exp. Med. 220, e20221346 (2023).","journal-title":"J. Exp. Med."},{"key":"2146_CR45","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-3083.2011.02549.x","volume":"74","author":"A\u2010CR Beitnes","year":"2011","unstructured":"Beitnes, A. \u2010C. R. et al. Density of CD163+CD11c+ dendritic cells increases and CD103+ dendritic cells decreases in the coeliac lesion. Scand. J. Immunol. 74, 186\u2013194 (2011).","journal-title":"Scand. J. Immunol."},{"key":"2146_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108661","volume":"34","author":"MEB FitzPatrick","year":"2021","unstructured":"FitzPatrick, M. E. B. et al. Human intestinal tissue-resident memory T cells comprise transcriptionally and functionally distinct subsets. Cell Rep. 34, 108661 (2021).","journal-title":"Cell Rep."},{"key":"2146_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi9591","volume":"376","author":"J Li","year":"2022","unstructured":"Li, J. et al. KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science 376, eabi9591 (2022).","journal-title":"Science"},{"key":"2146_CR48","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1053\/j.gastro.2021.06.025","volume":"161","author":"SC Sasson","year":"2021","unstructured":"Sasson, S. C. et al. Interferon-gamma\u2013producing CD8+ tissue resident memory T cells are a targetable hallmark of immune checkpoint inhibitor\u2013colitis. Gastroenterology 161, 1229\u20131244 (2021).","journal-title":"Gastroenterology"},{"key":"2146_CR49","doi-asserted-by":"publisher","unstructured":"Corridoni, D. et al. Single-cell atlas of colonic CD8+ T cells in ulcerative colitis. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-020-1003-4 (2020).","DOI":"10.1038\/s41591-020-1003-4"},{"key":"2146_CR50","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","volume":"178","author":"JC Martin","year":"2019","unstructured":"Martin, J. C. et al. Single-cell analysis of Crohn\u2019s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy. Cell 178, 1493\u20131508 (2019).","journal-title":"Cell"},{"key":"2146_CR51","doi-asserted-by":"publisher","unstructured":"Mayassi, T. et al. Chronic inflammation permanently reshapes tissue-resident immunity in celiac disease. Cell https:\/\/doi.org\/10.1016\/j.cell.2018.12.039 (2019).","DOI":"10.1016\/j.cell.2018.12.039"},{"key":"2146_CR52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2018.08.067","volume":"175","author":"J Kinchen","year":"2018","unstructured":"Kinchen, J. et al. Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease. Cell 175, 372\u2013386 (2018).","journal-title":"Cell"},{"key":"2146_CR53","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41586-018-0084-4","volume":"557","author":"M Shoshkes-Carmel","year":"2018","unstructured":"Shoshkes-Carmel, M. et al. Subepithelial telocytes are an important source of Wnts that supports intestinal crypts. Nature 557, 242\u2013246 (2018).","journal-title":"Nature"},{"key":"2146_CR54","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41385-021-00389-4","volume":"14","author":"UM M\u00f6rbe","year":"2021","unstructured":"M\u00f6rbe, U. M. et al. Human gut-associated lymphoid tissues (GALT); diversity, structure, and function. Mucosal Immunol. 14, 793\u2013802 (2021).","journal-title":"Mucosal Immunol."},{"key":"2146_CR55","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.immuni.2020.02.001","volume":"52","author":"TM Fenton","year":"2020","unstructured":"Fenton, T. M. et al. Immune profiling of human gut-associated lymphoid tissue identifies a role for isolated lymphoid follicles in priming of region-specific immunity. Immunity 52, 557\u2013570 (2020).","journal-title":"Immunity"},{"key":"2146_CR56","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ajg.2017.480","volume":"113","author":"DC Adelman","year":"2018","unstructured":"Adelman, D. C. et al. Measuring change in small intestinal histology in patients with celiac disease. Am. J. Gastroenterol. 113, 339\u2013347 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"2146_CR57","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1038\/s41591-023-02613-z","volume":"29","author":"OV Britanova","year":"2023","unstructured":"Britanova, O. V. et al. Targeted depletion of TRBV9+ T cells as immunotherapy in a patient with ankylosing spondylitis. Nat. Med. 29, 2731\u20132736 (2023).","journal-title":"Nat. Med."},{"key":"2146_CR58","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nri3919","volume":"15","author":"B Jabri","year":"2015","unstructured":"Jabri, B. & Abadie, V. IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction. Nat. Rev. Immunol. 15, 771\u2013783 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"2146_CR59","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nri2670","volume":"9","author":"B Jabri","year":"2009","unstructured":"Jabri, B. & Sollid, L. M. Tissue-mediated control of immunopathology in coeliac disease. Nat. Rev. Immunol. 9, 858\u2013870 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"2146_CR60","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.cell.2018.08.063","volume":"175","author":"AE Moor","year":"2018","unstructured":"Moor, A. E. et al. Spatial reconstruction of single enterocytes uncovers broad zonation along the intestinal villus axis. Cell 175, 1156\u20131167 (2018).","journal-title":"Cell"},{"key":"2146_CR61","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41575-024-00962-9","volume":"21","author":"T Bildstein","year":"2024","unstructured":"Bildstein, T., Charbit-Henrion, F., Azabdaftari, A., Cerf-Bensussan, N. & Uhlig, H. H. Cellular and molecular basis of proximal small intestine disorders. Nat. Rev. Gastroenterol. Hepatol. 21, 687\u2013709 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2146_CR62","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41385-018-0047-y","volume":"11","author":"L Konnikova","year":"2018","unstructured":"Konnikova, L. et al. High-dimensional immune phenotyping and transcriptional analyses reveal robust recovery of viable human immune and epithelial cells from frozen gastrointestinal tissue. Mucosal Immunol. 11, 1684\u20131693 (2018).","journal-title":"Mucosal Immunol."},{"key":"2146_CR63","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-62703-290-2_13","volume":"979","author":"RA Barnitz","year":"2013","unstructured":"Barnitz, R. A., Imam, S., Yates, K. & Haining, W. N. Isolation of RNA and the synthesis and amplification of cDNA from antigen-specific T cells for genome-wide expression analysis. Methods Mol. Biol. 979, 161\u2013173 (2013).","journal-title":"Methods Mol. Biol."},{"key":"2146_CR64","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.2232","volume":"16","author":"M Quigley","year":"2010","unstructured":"Quigley, M. et al. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat. Med. 16, 1147\u20131151 (2010).","journal-title":"Nat. Med."},{"key":"2146_CR65","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nmeth.2639","volume":"10","author":"S Picelli","year":"2013","unstructured":"Picelli, S. et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat. Methods 10, 1096\u20131098 (2013).","journal-title":"Nat. Methods"},{"key":"2146_CR66","doi-asserted-by":"publisher","unstructured":"FitzPatrick, M. & Antanaviciute, A. Immune-epithelial-stromal networks define the cellular ecosystem of the small intestine in celiac disease. Zenodo https:\/\/doi.org\/10.5281\/zenodo.15069144 (2025).","DOI":"10.5281\/zenodo.15069144"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02146-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02146-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02146-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:01:58Z","timestamp":1748970118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02146-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2146"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02146-2","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"10 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.E.B.F. consults for Takeda Pharmaceuticals. N.M.P. has consulted for Infinitopes. D.R. is an employee of Janssen Immunology. D. Aschenbrenner is an employee of Novartis Institute of BioMedical Research. S.A.T. is a scientific advisory board member of ForeSite Labs, OMass Therapeutics, Qiagen and Xaira Therapeutics, a cofounder and equity holder of TransitionBio and Ensocell Therapeutics, a non-executive director of 10x Genomics, and a part-time employee of GlaxoSmithKline. J.A.T. consults for GSK, Vesalius, Avammune, Azenta, Dasman Diabetes Institute and Immunocore. P.K. has consulted for AZ, Infinitopes and UCB, and received research funding from Immunocore, all on unrelated projects. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}